Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Samuel C Nash"'
Autor:
David Longmire, Haley Woods, Phillip B Rawlins, Jessie Hao-Ru Hsu, Daniel H O' Donovan, Alexandra Borodovsky, Peng Wang, Sharan K Bagal, Shaun M Fillery, Peter Barton, Clare Gregson, Beth Williamson, Samuel C Nash, Andrew Pike, Jon A Read, Kurt Gordon Pike, Andrew Bloecher, Erin Code, Minhui Shen, Sameer Kawatkar, Youfeng Nai, Jia Tang, Chengzhi Li, James C. Robinson
Publikováno v:
Journal of Medicinal Chemistry. 64:17146-17183
Aberrant activity of the histone methyltransferase polycomb repressive complex 2 (PRC2) has been linked to several cancers, with small-molecule inhibitors of the catalytic subunit of the PRC2 enhancer of zeste homologue 2 (EZH2) being recently approv
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cfbef686d9310c0393124b8f8df7ca38
https://doi.org/10.1021/acs.jmedchem.1c01161
https://doi.org/10.1021/acs.jmedchem.1c01161
Autor:
Akosua B. Anane-Adjei, Esther Jacobs, Samuel C. Nash, Sean Askin, Ramesh Soundararajan, Mary Kyobula, Jonathan Booth, Andrew Campbell
Publikováno v:
International journal of pharmaceutics. 614
The poor aqueous solubility of many active pharmaceutical ingredients (APIs) dominates much of the early drug development portfolio and poses a major challenge in pharmaceutical development. Polymer-based amorphous solid dispersions (ASDs) are becomi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::db72a3dd5a0464fc87bb7650d03e9079
https://pubmed.ncbi.nlm.nih.gov/34933082
https://pubmed.ncbi.nlm.nih.gov/34933082